Diabetes Relief: Major Manufacturers Cap Insulin Prices at $35, Answering Calls for Affordability in the US Novo Nordisk, Sanofi, and Eli Lily are working together to make insulin less costly for millions of people in the US suffering from diabetes. by Quincy Jon
Health Eli Lilly's Weight-Loss Drug Users Regain Over 20 Pounds After Discontinuation, Study Reveals by Quincy Jon
Healthy Living/Wellness Cholesterol Drug Evacetrapib Does Not Reduce Cardiovascular Events by Katrina Pascual
Healthy Living/Wellness Eli Lilly's Jardiance Diabetes Treatment Steals Market Share From Rival Drugs by Katrina Pascual
Healthy Living/Wellness FDA Approves Eli Lilly's Drug Basaglar For Diabetes Treatment by Katrina Pascual
Healthy Living/Wellness Eli Lilly, Incyte Announce Baricitinib Superior To Methotrexate In Alleviating Rheumatoid Arthritis by Dianne Depra